SCHEMBL20380388

SCHEMBL20380388

CS(=O)(=O)c1nc(N)c2ncc(C3(O)O[C@@H]4C(OCc5ccccc5)[C@]4(OCc4ccccc4)[C@H]3OCc3ccccc3)n2n1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 2/20 0.32
▸ MERTK Q12866 2/20 0.31
▸ AXL P30530 1/20 0.31
▸ BCHE P06276 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19997433 0.81 TLR7 (0.31) TLR7
SCHEMBL23278043 0.81 TLR7 (0.31) TLR7
SCHEMBL12243227 0.81 PDE2A (0.37) TLR7MERTKAXLBCHE
SCHEMBL12243231 0.78 HSPA5 (0.33) TLR7BCHE
SCHEMBL20380391 0.76 TLR7 (0.30) TLR7
SCHEMBL12393306 0.75 TLR7 (0.32) TLR7
SCHEMBL12243233 0.73 PDE2A (0.31) —
SCHEMBL20756112 0.73 TNK2 (0.33) BCHE
SCHEMBL19997421 0.73 TNK2 (0.33) BCHE
SCHEMBL19997394 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023600-B2 Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs GILEAD SCIENCES, INC. (US) 2018-07-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023600-B2 Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs PNP, TYMP, CDA TLR7 2212/4885MERTK 3935/4885AXL 2585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback